Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23803,977,0.95 [0.82-1.11],0.531582548020935
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,23721,191,1.11 [0.80-1.54],0.5320314615350004
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,25693,185,0.87 [0.61-1.24],0.4412470578322056
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18151,752,0.97 [0.81-1.16],0.7556144660586169
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,25628,120,0.84 [0.54-1.31],0.436742111997715
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,24586,83,1.13 [0.69-1.86],0.6150662878974982
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27045,119,0.84 [0.53-1.31],0.437163973193892
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27039,80,0.61 [0.35-1.09],0.0964000625996944
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,23965,66,1.63 [1.05-2.52],0.0299529646879035
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,26386,119,0.96 [0.62-1.48],0.8460788130649101
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other septicaemia,26337,70,1.10 [0.64-1.89],0.7203622629473041
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27122,78,1.15 [0.70-1.89],0.5869790289953438
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27090,101,1.14 [0.73-1.77],0.5623043444833835
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27086,97,1.16 [0.74-1.81],0.5246128897012508
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Mycoses,26753,63,1.03 [0.58-1.84],0.915004027692971
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",25937,431,0.91 [0.72-1.15],0.4309368599900441
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,25636,130,0.97 [0.64-1.47],0.8951146850508855
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,25803,297,0.86 [0.65-1.14],0.2935037735055047
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",22200,48,0.95 [0.48-1.87],0.8733138404831364
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22216,64,nan [nan-nan],
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",22400,248,nan [nan-nan],
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",22407,255,0.93 [0.93-0.93],0.0
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",22811,659,1.18 [0.99-1.40],0.0594144454848656
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22203,51,1.19 [0.66-2.16],0.5588223938971077
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,24329,1018,0.89 [0.77-1.04],0.1415141329725063
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",26076,278,0.91 [0.68-1.21],0.5112099931409331
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,26794,101,1.02 [0.65-1.61],0.9254416045667828
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27220,86,0.79 [0.46-1.34],0.3817997551169048
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Rectum,27004,55,1.16 [0.64-2.11],0.6194594247615848
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27216,71,0.71 [0.39-1.29],0.2544957229640708
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Stomach,27263,56,0.84 [0.43-1.61],0.5951537356304982
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm,27037,272,0.68 [0.50-0.92],0.0124030733970851
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27211,108,0.56 [0.34-0.92],0.0228419779214549
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27210,104,0.81 [0.50-1.31],0.3868866404681051
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27143,70,0.66 [0.36-1.21],0.1802906034863228
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Haemangioma, any site",27145,69,0.69 [0.38-1.28],0.2395933830188622
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Melanocytic naevi,27054,266,0.83 [0.62-1.12],0.2288030361722109
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,27221,120,0.97 [0.63-1.48],0.8778053935980844
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Other benign neoplasms of skin,27111,229,0.88 [0.64-1.21],0.4255302061552222
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of breast,27201,135,1.32 [0.93-1.88],0.1176650814842173
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Leiomyoma of uterus,26697,995,0.83 [0.71-0.97],0.0182865517408351
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,25870,266,1.09 [0.82-1.43],0.5551344789999944
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,25606,444,0.86 [0.68-1.08],0.1871011799325097
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,25606,444,0.86 [0.68-1.08],0.1871011799325097
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),24082,409,1.14 [0.91-1.43],0.2410338699516263
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,26703,94,0.77 [0.46-1.28],0.3076485648307692
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,26913,108,1.52 [1.06-2.19],0.0229497572260868
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22626,913,1.12 [0.97-1.31],0.1325415257681027
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,24963,889,0.97 [0.83-1.14],0.7434935632816654
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,25432,121,1.03 [0.67-1.58],0.885497744780512
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26263,60,0.82 [0.44-1.54],0.5407156511669352
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25418,107,1.05 [0.67-1.64],0.8403912671501297
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,25720,409,1.02 [0.80-1.30],0.8638620565806442
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,25710,399,1.02 [0.80-1.29],0.897489004148864
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,25196,197,1.16 [0.82-1.64],0.4001931400201721
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",25199,194,1.14 [0.81-1.62],0.454745181385592
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22438,725,1.09 [0.91-1.29],0.3575652168431443
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",21797,84,1.03 [0.62-1.70],0.9080015396875628
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,22384,671,1.10 [0.92-1.31],0.3206233731637719
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,21762,49,1.77 [1.11-2.83],0.0163316860646223
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21781,68,1.41 [0.88-2.26],0.153028099955334
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Any mental disorder,22975,612,1.00 [0.83-1.22],0.9785142093083748
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",22478,115,1.42 [0.96-2.09],0.0771451248421088
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27027,77,1.25 [0.76-2.07],0.3793504353976578
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27065,45,1.95 [1.21-3.14],0.0062980792690043
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,25827,37,0.42 [0.18-1.01],0.0527194913017693
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",27216,37,0.42 [0.17-0.99],0.04847265581566
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",22400,37,0.42 [0.18-1.00],0.0493993223135546
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Alcohol dependence,25813,23,1.98 [1.06-3.70],0.0319831399297214
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Smoking dependency,25706,34,1.82 [1.02-3.24],0.0437902192859128
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",22406,43,0.96 [0.46-1.97],0.9033922168984644
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",22744,381,0.88 [0.69-1.13],0.3162602517057871
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Depression,25272,337,0.83 [0.63-1.08],0.1652509319692074
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Depression or dysthymia,22527,296,0.83 [0.62-1.10],0.1888722706860882
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",22508,145,1.21 [0.84-1.73],0.3086913415552735
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Other anxiety disorders,25351,72,1.03 [0.60-1.78],0.9108919474956384
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Neurological diseases,23490,1614,0.87 [0.76-0.98],0.0248967227688094
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,21475,175,0.72 [0.49-1.06],0.094267573999742
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27067,147,0.72 [0.47-1.08],0.1112527982347126
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,25948,418,0.77 [0.61-0.99],0.0389992673771087
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Epilepsy,25666,136,0.59 [0.38-0.91],0.0166327273761348
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Migraine,25656,126,0.82 [0.53-1.26],0.3625957498025219
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",26834,116,0.86 [0.55-1.35],0.5217128993369062
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Transient ischemic attack,26573,60,1.16 [0.65-2.05],0.6176968200669708
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other sleep disorders,25624,94,0.98 [0.60-1.58],0.9253979771742896
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Sleep apnoea,26852,67,0.69 [0.38-1.28],0.241084650157742
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",25896,854,0.95 [0.80-1.12],0.5297434786614483
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",25163,121,1.08 [0.71-1.62],0.7304083745250747
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,25585,543,0.94 [0.76-1.15],0.5292958006703141
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27005,75,0.50 [0.28-0.92],0.0247998732054651
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Hemiplegia,26987,57,0.31 [0.16-0.63],0.0011971192749352
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other neurological diseases,26776,121,0.70 [0.45-1.11],0.1344933610222154
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",26530,421,0.75 [0.59-0.96],0.0215756114649215
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,26357,248,0.69 [0.50-0.95],0.0224396239472074
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26181,72,0.71 [0.39-1.27],0.2482649998833709
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26244,135,0.69 [0.45-1.07],0.0952210895439359
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26214,105,0.70 [0.43-1.15],0.1623900038706436
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23167,179,1.08 [0.76-1.52],0.6761571028932005
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23390,402,1.14 [0.91-1.43],0.2651310059483246
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,26236,185,0.86 [0.60-1.23],0.4100795398093178
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,26997,35,1.28 [0.62-2.66],0.5070847701040164
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1762,35,1.10 [0.51-2.38],0.7995188113290181
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",25270,35,1.30 [0.63-2.69],0.4775179913323292
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,26565,94,1.09 [0.68-1.74],0.723280804780724
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,26524,53,1.09 [0.58-2.04],0.7973708691273201
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",26433,96,1.25 [0.81-1.92],0.3203464537112502
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,26696,105,0.77 [0.48-1.25],0.2925502073119852
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,27139,128,0.90 [0.59-1.37],0.6221828063262627
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,26474,106,0.86 [0.53-1.37],0.5165756504154635
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,20073,2767,1.05 [0.95-1.17],0.3136241963048876
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,26689,72,1.73 [1.17-2.57],0.0064153443636957
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21085,2045,1.04 [0.93-1.17],0.4840029811227975
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypertension,21107,2067,1.04 [0.93-1.17],0.5021275743555207
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19088,48,1.37 [0.75-2.48],0.3033651913859408
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",25598,720,1.04 [0.87-1.25],0.6335624552415738
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Angina pectoris,25377,499,1.02 [0.82-1.26],0.8611825832616122
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,26599,145,1.17 [0.81-1.69],0.4062565335231702
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,26679,225,1.24 [0.93-1.66],0.1425990839587681
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27194,28,1.00 [0.41-2.41],0.992414767518299
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",24975,97,1.30 [0.84-2.00],0.2436120313498366
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,25347,481,1.09 [0.88-1.35],0.4185593107700295
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Pulmonary embolism,26476,99,1.21 [0.78-1.87],0.3928192595778337
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Venous thromboembolism,26575,216,0.84 [0.60-1.17],0.3060423612367087
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Secondary right heart disease,26471,94,1.72 [1.22-2.44],0.002136474047745
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,26471,94,1.72 [1.22-2.44],0.002136474047745
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19131,91,1.65 [1.14-2.39],0.0082110780539095
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Cardiomyopathy,23689,38,1.67 [0.94-2.98],0.082733296959769
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Conduction disorders,23729,78,0.73 [0.41-1.28],0.2739236762469007
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16377,101,0.72 [0.44-1.19],0.2004297899677388
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16547,271,1.25 [0.95-1.64],0.1089532195617963
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other arrhythmias,23702,51,1.59 [0.95-2.67],0.0787776179583442
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,23707,56,1.06 [0.57-1.98],0.8478299715197141
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Heart failure, strict",26425,98,1.39 [0.91-2.12],0.128527673142081
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",26488,129,0.79 [0.51-1.22],0.2949525567045729
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",26529,97,0.72 [0.43-1.20],0.2076755699310639
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",26598,85,0.72 [0.42-1.23],0.2292996297749466
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,26284,68,1.50 [0.95-2.37],0.080055375578156
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,26327,111,1.16 [0.76-1.77],0.4822129501835338
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),25662,131,0.63 [0.40-0.98],0.041300394779515
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,DVT of lower extremities,25636,105,0.64 [0.39-1.06],0.0809127132068383
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27052,102,0.61 [0.37-1.00],0.051587552777762
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Varicose veins,26125,594,0.99 [0.82-1.20],0.9213290498184692
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypotension,26127,90,0.63 [0.37-1.08],0.0923050714512647
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22142,2076,0.97 [0.87-1.08],0.553363782491669
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27048,127,1.09 [0.73-1.62],0.6788699371537281
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Influenza and pneumonia,25635,195,1.35 [1.01-1.80],0.0410452197385965
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",25616,176,1.34 [0.99-1.82],0.062109974391742
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,26362,228,1.06 [0.78-1.43],0.7281033024065162
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,26354,220,1.09 [0.81-1.48],0.5621332804958037
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,26495,553,0.84 [0.68-1.03],0.0930456107751394
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Chronic sinusitis,26056,114,0.80 [0.50-1.26],0.3318958448732608
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Nasal polyp,26021,79,1.18 [0.72-1.92],0.5118417843966074
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26291,349,0.73 [0.56-0.96],0.0228535301746786
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Deviated nasal septum,26081,139,0.63 [0.41-0.97],0.0367125160777787
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13116,62,0.73 [0.39-1.39],0.3430407163891099
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,24335,1152,0.97 [0.84-1.11],0.6229886758028358
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Early onset COPD,26210,156,1.07 [0.74-1.54],0.7265504864627763
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",26230,176,0.98 [0.69-1.39],0.9106556744747462
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",26230,176,0.98 [0.69-1.39],0.9106556744747462
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",25229,991,0.98 [0.84-1.14],0.817371927935986
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Asthma,20235,991,0.99 [0.85-1.16],0.9126705411260638
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",20046,991,0.99 [0.85-1.16],0.932402732035894
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",20220,976,0.97 [0.83-1.13],0.6981780164078246
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,26939,85,1.52 [1.01-2.30],0.0443064078937108
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Interstitial lung disease,25491,64,1.61 [1.03-2.52],0.035389149282266
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",27015,64,1.63 [1.05-2.55],0.0300601204883756
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,25484,57,1.40 [0.82-2.37],0.2139162569313741
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pleural effusion,25430,85,0.86 [0.51-1.45],0.568609744182082
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other diseases of pleura,25531,186,1.19 [0.86-1.65],0.2827392951740444
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,26097,89,1.44 [0.95-2.20],0.0888944683831349
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18871,5937,0.96 [0.89-1.03],0.2406430153799064
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",26704,465,1.06 [0.86-1.31],0.6022668658978048
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27220,100,0.89 [0.55-1.43],0.629945529320029
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Impacted teeth,27225,90,0.90 [0.54-1.48],0.6644678842953421
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Dental caries,26343,104,1.29 [0.85-1.94],0.2298011281216633
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26358,119,0.99 [0.64-1.52],0.957718986251154
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27212,111,0.89 [0.57-1.40],0.6250707499506352
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26352,113,1.03 [0.67-1.59],0.8779163996103003
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26052,78,1.52 [1.00-2.31],0.0491347909204683
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27124,49,1.73 [1.08-2.77],0.0224672892140116
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,20593,219,0.76 [0.55-1.07],0.1186157447070406
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22678,2304,0.92 [0.82-1.02],0.1035943816978754
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oesophagitis,20663,289,1.06 [0.81-1.39],0.6883983373914668
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21105,731,0.85 [0.70-1.02],0.0747441134192708
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,20451,77,0.90 [0.52-1.56],0.7074149125409028
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,20506,132,0.71 [0.46-1.10],0.122318844842756
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oesophageal obstruction,20412,38,0.63 [0.27-1.44],0.2729032455730594
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastric ulcer,20518,144,0.67 [0.44-1.03],0.0667790914428041
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Duodenal ulcer,20450,76,1.13 [0.68-1.88],0.640635582353007
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27173,54,1.04 [0.56-1.93],0.9066461617787566
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Chronic gastritis,20508,134,0.82 [0.54-1.26],0.3679884112554714
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),21209,835,0.91 [0.77-1.08],0.2799168407735362
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of appendix,27094,143,0.89 [0.60-1.33],0.5815289920969484
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Functional dyspepsia,20953,579,1.05 [0.87-1.27],0.6168064763840981
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,20551,177,1.01 [0.71-1.43],0.957056635161486
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27131,139,0.69 [0.45-1.06],0.0876717521186266
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute appendicitis,27065,114,0.89 [0.57-1.40],0.6181635676586725
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Hernia,24380,1186,0.93 [0.81-1.08],0.3333547696785833
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Inguinal hernia,23262,68,1.32 [0.80-2.17],0.2708666338721824
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Umbilical hernia,23264,70,1.32 [0.81-2.16],0.2627694597727011
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ventral hernia,23299,105,0.57 [0.34-0.93],0.0257156998405623
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,24145,951,0.92 [0.78-1.08],0.3004122910789829
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26182,904,1.06 [0.91-1.24],0.4266988434334376
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of intestines,21566,2152,0.90 [0.80-1.00],0.0575015367370641
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",26916,60,nan [nan-nan],
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",27187,85,0.70 [0.41-1.21],0.2024969085706577
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Crohn disease,25363,85,0.70 [0.41-1.21],0.2045499831503034
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Crohn's disease NAS,25339,61,0.71 [0.38-1.36],0.3060187874397195
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",27114,128,0.98 [0.65-1.49],0.9383415708373488
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ulcerative colitis,25406,128,0.98 [0.65-1.49],0.9363604532429604
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",25392,114,1.03 [0.67-1.60],0.8765990641234064
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26050,772,1.11 [0.95-1.31],0.1968674855585662
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26039,761,1.11 [0.94-1.31],0.2032993935209858
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,19518,104,0.70 [0.42-1.15],0.1557223607810746
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Intestinal stricture,26790,104,0.72 [0.44-1.18],0.1920528855445188
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",19478,64,0.67 [0.35-1.27],0.2206527253573655
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20077,663,0.98 [0.81-1.18],0.8279090092635532
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,19652,238,1.00 [0.74-1.35],0.982965394298192
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19805,391,1.01 [0.80-1.28],0.9254741121555868
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Constipation,25566,348,1.01 [0.79-1.30],0.9168913977090144
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of peritoneum,26748,123,1.14 [0.77-1.70],0.5103985765716706
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,19536,122,0.69 [0.44-1.08],0.1065103183463804
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,19459,45,0.67 [0.31-1.41],0.2900160164458724
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,20284,870,0.88 [0.75-1.04],0.1367249383317741
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of intestine,19644,230,0.76 [0.55-1.06],0.1067728366074203
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,26730,105,1.23 [0.81-1.86],0.3238365139624655
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of liver,26474,103,1.18 [0.76-1.81],0.463176367504541
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of liver,26422,51,1.32 [0.74-2.36],0.3417373634098202
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",25700,871,0.97 [0.82-1.14],0.707667334700097
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Cholelithiasis,25558,729,1.00 [0.84-1.20],0.958002317361493
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Cholecystitis,24958,129,1.05 [0.70-1.58],0.7998870429496976
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,24898,69,0.72 [0.39-1.31],0.2807509473742049
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute pancreatitis,24889,60,1.21 [0.69-2.14],0.5004861123301281
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),27101,60,1.21 [0.69-2.13],0.4989464292711399
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of the digestive system,25880,308,1.24 [0.97-1.59],0.0794698665543231
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Intestinal malabsorption,25676,104,0.86 [0.54-1.39],0.547065325713424
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Coeliac disease,25660,88,0.91 [0.55-1.51],0.7075514308627098
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",25613,41,1.09 [0.54-2.22],0.8064299630676975
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,25740,168,1.48 [1.10-2.00],0.0101279357490369
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,GI-bleeding,25730,158,1.46 [1.07-2.00],0.0165112110097408
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,24127,1599,0.94 [0.83-1.07],0.3453713619918609
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,26801,109,0.99 [0.63-1.55],0.9674461993429372
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,26804,453,0.87 [0.69-1.09],0.2289845727556438
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,25703,693,0.91 [0.76-1.10],0.3336283878270339
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,26443,316,0.97 [0.75-1.27],0.8411111798577371
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26196,69,0.89 [0.50-1.59],0.7010916775038708
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,26327,200,1.14 [0.83-1.57],0.411094271964889
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,26967,88,1.39 [0.91-2.14],0.1303622436957463
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,26941,62,1.38 [0.82-2.30],0.2239608679797643
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,26927,48,1.55 [0.90-2.65],0.1109184275163559
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,26987,54,1.05 [0.56-1.96],0.8806167150768044
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,26984,51,0.88 [0.45-1.74],0.7161892389130678
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26407,56,0.65 [0.33-1.27],0.2033732344993652
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,26708,357,0.95 [0.74-1.22],0.6997983430990682
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25113,103,0.90 [0.56-1.45],0.6591949684856931
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25163,153,0.62 [0.41-0.94],0.0235028166933957
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25122,112,0.64 [0.40-1.04],0.0731212075018388
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",25264,254,1.04 [0.78-1.39],0.7663193375847642
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,25238,228,1.04 [0.77-1.41],0.7926150469568396
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19197,4366,0.95 [0.88-1.03],0.2336839522712781
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20926,2511,0.99 [0.90-1.10],0.8935912214109382
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,24468,1330,0.92 [0.80-1.05],0.1983108536240339
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18624,209,1.13 [0.83-1.54],0.4426501875477753
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18934,519,0.98 [0.79-1.21],0.8543842374609991
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",26682,200,1.11 [0.81-1.52],0.530608580987429
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,26701,185,1.12 [0.81-1.55],0.4975424843071681
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19634,1219,1.02 [0.88-1.18],0.783141899259794
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",22308,1219,1.03 [0.89-1.18],0.6944514079744265
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18428,13,0.18 [0.04-0.80],0.0240602760109242
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27058,13,0.23 [0.05-0.99],0.0484229049354311
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18696,281,0.87 [0.65-1.17],0.3609099205033783
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18503,88,0.79 [0.46-1.35],0.3854346248115635
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18720,305,1.08 [0.82-1.41],0.5852402458770383
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27061,155,1.16 [0.81-1.66],0.4177522246448368
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18895,480,1.14 [0.92-1.41],0.232163806334149
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18900,485,0.94 [0.75-1.18],0.5952539020516396
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19820,1405,1.01 [0.89-1.15],0.8785826762728584
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18522,107,0.84 [0.52-1.36],0.4749772721238532
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18835,420,0.94 [0.74-1.19],0.62593593603924
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18497,82,1.24 [0.77-1.99],0.3733344409058406
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18516,101,1.37 [0.91-2.06],0.1372518194436043
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18781,366,1.16 [0.92-1.46],0.2158039582856232
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18725,310,1.23 [0.96-1.57],0.1014608350953236
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,20295,297,1.03 [0.79-1.36],0.8169988329039348
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,26448,219,0.93 [0.67-1.28],0.6488038538792471
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,26322,93,1.08 [0.68-1.73],0.7332059664234881
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,23310,81,0.83 [0.48-1.43],0.502686838630739
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,23531,302,0.89 [0.67-1.18],0.4269280726200367
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,24250,1021,1.02 [0.88-1.19],0.7445593919155914
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,23441,212,0.94 [0.68-1.31],0.7137979853636678
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,23306,77,0.91 [0.53-1.58],0.7446470491572852
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",24045,816,1.09 [0.92-1.28],0.3119239391827799
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23280,51,0.54 [0.26-1.12],0.0981083269520146
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,23475,246,1.20 [0.90-1.58],0.2093761137664357
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,23331,102,1.26 [0.82-1.91],0.2907551458803605
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,23320,91,1.58 [1.07-2.33],0.0224045240772993
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,23392,163,1.42 [1.04-1.94],0.029316020338472
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,23304,75,0.94 [0.54-1.63],0.8319731278494504
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,23580,351,1.14 [0.90-1.45],0.2853911830707553
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,23520,382,0.81 [0.63-1.04],0.0958695183267646
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23208,70,0.73 [0.40-1.33],0.3045710258854202
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23249,111,0.74 [0.46-1.19],0.2120479759964635
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23281,143,0.76 [0.50-1.16],0.2036673821256664
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23175,37,1.21 [0.60-2.44],0.58694115335138
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23196,58,0.64 [0.33-1.25],0.1891905891681518
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23180,42,1.09 [0.54-2.19],0.810990247000213
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,23415,277,0.96 [0.72-1.27],0.7667364250223793
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23196,58,0.92 [0.49-1.71],0.7832756712095725
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,23207,69,1.22 [0.72-2.07],0.4542461574814912
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23276,138,0.87 [0.58-1.32],0.5181682674263833
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23219,81,0.75 [0.43-1.30],0.2989147542420168
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",23676,538,0.93 [0.75-1.14],0.4680195417474044
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,23331,193,0.85 [0.60-1.21],0.3655649444628723
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,23428,290,0.92 [0.70-1.22],0.578546708739115
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,24527,235,0.93 [0.68-1.27],0.6648105569219505
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,24774,482,0.87 [0.70-1.09],0.2172207862798976
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,24332,40,1.24 [0.64-2.43],0.5246756405233974
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,24356,64,0.89 [0.49-1.62],0.7079112514796545
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,24406,114,0.87 [0.55-1.36],0.5323889359506042
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,22231,6060,0.96 [0.90-1.03],0.293135664958088
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,24814,199,1.04 [0.75-1.44],0.8300486519422032
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,24659,44,0.56 [0.26-1.22],0.1451791944260227
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Acute renal failure,24983,36,1.71 [0.95-3.07],0.0743882978041288
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,24994,47,1.19 [0.63-2.26],0.5949608488432647
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,24989,42,1.78 [1.08-2.93],0.0246270710494049
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27012,130,1.18 [0.81-1.73],0.3858877523403892
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,26891,63,1.52 [0.95-2.42],0.0820453580581441
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,26980,98,1.21 [0.79-1.87],0.3782730463245271
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,26917,35,0.98 [0.45-2.15],0.9589286242962016
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,25058,1236,0.94 [0.82-1.08],0.3766784375681788
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Cystitis,23957,135,0.86 [0.56-1.31],0.4793855819572905
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,23905,83,0.70 [0.40-1.22],0.2106377969888081
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,23988,166,0.77 [0.53-1.14],0.1921500069925421
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Urethral stricture,23910,88,0.81 [0.48-1.38],0.4414191204801012
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,24795,973,0.97 [0.83-1.13],0.6920250247664593
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Disorders of breast,26940,475,1.22 [1.00-1.49],0.0482709529770382
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26613,148,0.66 [0.44-1.01],0.0542075512239393
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,26633,168,1.52 [1.15-2.02],0.0036248598745541
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26575,110,1.48 [1.03-2.12],0.0346513063505857
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,26876,550,0.89 [0.73-1.10],0.2791725138778987
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,26459,133,0.83 [0.55-1.27],0.397564327616035
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26573,247,0.94 [0.70-1.27],0.6786456233944846
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,24820,4531,0.92 [0.85-0.99],0.0320174177829168
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Endometriosis,20650,361,0.70 [0.54-0.91],0.0078196009724592
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,20388,99,0.87 [0.54-1.40],0.5596237240206126
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20454,165,0.49 [0.33-0.74],0.0005900129460145
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21063,774,0.85 [0.71-1.02],0.0777146643430233
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20691,402,0.78 [0.61-0.99],0.0442769338922548
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21231,942,0.97 [0.83-1.13],0.6750239385090164
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20602,313,0.80 [0.60-1.06],0.1135858854937743
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20725,436,0.75 [0.59-0.95],0.0159423002366997
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,20387,98,1.28 [0.85-1.93],0.2457215206765526
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,20475,186,0.82 [0.57-1.17],0.2655491354674678
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",27217,266,0.88 [0.65-1.18],0.3892790134007831
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,27228,252,0.87 [0.65-1.18],0.383993705815825
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,27253,138,0.98 [0.66-1.46],0.9343889290361306
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",27243,152,1.00 [0.69-1.46],0.9973406170253598
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20431,142,0.89 [0.60-1.33],0.5831147483732408
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20402,113,0.53 [0.33-0.87],0.0109402720424048
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20425,136,1.16 [0.80-1.68],0.4270394408288517
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Irregular menses,27147,464,1.04 [0.84-1.28],0.7454873424289736
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21623,1334,0.92 [0.81-1.05],0.2290459208503065
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21162,873,0.83 [0.70-0.98],0.0268356290780905
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",27233,194,1.22 [0.90-1.66],0.204593718736468
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20742,453,0.78 [0.61-0.98],0.0318481928503008
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20611,322,0.97 [0.75-1.26],0.8290437951294425
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21180,891,0.98 [0.84-1.15],0.8254494887743438
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Female infertility,20403,114,0.95 [0.61-1.47],0.8171943571266757
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",20396,107,0.89 [0.56-1.41],0.6079824855786036
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,27250,862,0.84 [0.70-1.00],0.0530645846498027
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,27256,1182,0.74 [0.63-0.87],0.0003412862777532
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,27250,469,1.03 [0.82-1.28],0.812952072667789
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,26918,137,0.82 [0.54-1.25],0.3510512501538763
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,26965,184,1.05 [0.75-1.48],0.7679991295643103
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,26945,164,1.20 [0.85-1.71],0.3035533774074026
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",27270,167,0.86 [0.59-1.25],0.4367249951379671
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,27272,164,0.83 [0.57-1.22],0.3524063614170687
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,27267,410,0.82 [0.64-1.05],0.1080204520457823
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,26981,124,0.98 [0.64-1.50],0.9419652889999994
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,27084,227,0.81 [0.58-1.12],0.2063506102126959
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,26532,144,0.84 [0.56-1.27],0.4104058054983772
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,26585,197,0.93 [0.66-1.31],0.6632531058329487
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,26633,245,0.79 [0.57-1.09],0.1507840005243428
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,26534,146,0.95 [0.64-1.42],0.8180278222494727
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,26523,135,0.79 [0.52-1.22],0.2914232951284079
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,26536,148,0.70 [0.46-1.07],0.099428799439536
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,26304,230,0.55 [0.38-0.78],0.0007741220667734
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],26502,428,0.70 [0.55-0.91],0.0066582911737125
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,26733,659,0.81 [0.66-1.00],0.0461808261986761
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",27271,171,0.69 [0.47-1.01],0.0548726539137115
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,25844,129,0.59 [0.37-0.93],0.0227025299992364
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26178,104,0.64 [0.39-1.05],0.0788552080814965
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,27279,331,0.72 [0.54-0.95],0.0204704500287986
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27198,250,0.66 [0.47-0.91],0.0108801374054635
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",27266,247,0.97 [0.71-1.32],0.8448608839719309
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",27256,237,0.94 [0.69-1.29],0.7209676811512654
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",26975,42,1.21 [0.62-2.37],0.5728969630215023
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Falls/tendency to fall,24379,640,0.95 [0.78-1.14],0.570165704050025
